BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23541143)

  • 1. The self-assessment scale of cognitive complaints in schizophrenia: a validation study in Tunisian population.
    Johnson I; Kebir O; Ben Azouz O; Dellagi L; Rabah Y; Tabbane K
    BMC Psychiatry; 2009 Oct; 9():66. PubMed ID: 19814827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric evaluation of the patient-reported experience of cognitive impairment in schizophrenia (PRECIS) scale.
    Lenderking WR; Atkinson MJ; Ladd MK; Savva Y; Sommer S; Sidovar M; Hastedt C
    J Patient Rep Outcomes; 2024 Jun; 8(1):61. PubMed ID: 38884842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis.
    Galderisi S; Rucci P; Kirkpatrick B; Mucci A; Gibertoni D; Rocca P; Rossi A; Bertolino A; Strauss GP; Aguglia E; Bellomo A; Murri MB; Bucci P; Carpiniello B; Comparelli A; Cuomo A; De Berardis D; Dell'Osso L; Di Fabio F; Gelao B; Marchesi C; Monteleone P; Montemagni C; Orsenigo G; Pacitti F; Roncone R; Santonastaso P; Siracusano A; Vignapiano A; Vita A; Zeppegno P; Maj M;
    JAMA Psychiatry; 2018 Apr; 75(4):396-404. PubMed ID: 29450447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assessment scale of auditory verbal hallucinations (SAVH): A novel tool for patients with schizophrenia.
    Dollfus S; Letourneur F; Métivier L; Moulier V; Rothärmel M
    Schizophr Res; 2024 May; 267():19-23. PubMed ID: 38513330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop.
    Bellack AS; Green MF; Cook JA; Fenton W; Harvey PD; Heaton RK; Laughren T; Leon AC; Mayo DJ; Patrick DL; Patterson TL; Rose A; Stover E; Wykes T
    Schizophr Bull; 2007 May; 33(3):805-22. PubMed ID: 16931542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.
    Dollfus S; Mach C; Morello R
    Schizophr Bull; 2016 May; 42(3):571-8. PubMed ID: 26564898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of psychopathology on day-to-day living in patients with schizophrenia: A network analysis.
    Redlich Bossy M; Müller DR; Niedermoser DW; Burrer A; Spiller TR; Vetter S; Seifritz E; Egger ST
    Compr Psychiatry; 2024 Aug; 133():152501. PubMed ID: 38820645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new schizophrenia screening instrument based on evaluating the patient's writing.
    Peng Z; Li Q; Liu X; Zhang H; Luosang-Zhuoma ; Ran M; Liu M; Tan X; Stein MJ
    Schizophr Res; 2024 Apr; 266():127-135. PubMed ID: 38401411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subscale structure for the Positive and Negative Syndrome Scale (PANSS): a proposed solution focused on clinical validity.
    Kelley ME; White L; Compton MT; Harvey PD
    Psychiatry Res; 2013 Jan; 205(1-2):137-42. PubMed ID: 22974521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing metamotivation in schizophrenia: A pilot study of the Brief Regulation of Motivation Scale (BRoMS).
    Lynch DA; Brown M; Saperstein A; Stefancic A; Medalia A
    Psychiatry Res; 2022 Nov; 317():114799. PubMed ID: 36037743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of the Spanish version of the Health of Nation Outcome Scales for schizophrenia patients.
    Feria-Raposo I; García-León MÁ; Rodríguez-Cano E; Blanco-Blanco J; Moreno-Casbas MT; Gonzalez-Castro AI; Gómez-Lozano MJ; Guerrero-Pedraza A; Sarri C; Portillo F; Sarró S; McKenna PJ; Salvador R; Pomarol-Clotet E
    J Psychiatr Ment Health Nurs; 2024 Mar; ():. PubMed ID: 38501552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and validation of standardized clinical and functional remission criteria in schizophrenia.
    Mosolov SN; Potapov AV; Ushakov UV; Shafarenko AA; Kostyukova AB
    Neuropsychiatr Dis Treat; 2014; 10():167-81. PubMed ID: 24511232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UNC Perceived Message Effectiveness: Validation of a Brief Scale.
    Baig SA; Noar SM; Gottfredson NC; Boynton MH; Ribisl KM; Brewer NT
    Ann Behav Med; 2019 Jul; 53(8):732-742. PubMed ID: 30321252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly.
    Correll CU; Brieden A; Janetzky W
    Schizophrenia (Heidelb); 2023 Nov; 9(1):80. PubMed ID: 37935711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) Among Patients with Schizophrenia.
    Isjanovski V; Naumovska A; Bonevski D; Novotni A
    Open Access Maced J Med Sci; 2016 Mar; 4(1):65-9. PubMed ID: 27275332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of functional mental capacity in forensic mental health practice: the Dundrum capacity ladders validation study.
    Moynihan G; O'Reilly K; O'Connor J; Kennedy HG
    BMC Psychiatry; 2018 Mar; 18(1):78. PubMed ID: 29580216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing schizophrenia in primary care: the utility of remission criteria as outcome indicators.
    Fear C; Yeomans D; Moore B; Taylor M; Ford K; Currie A; Hynes J; Sullivan G; Whale R; Burns T
    Ment Health Fam Med; 2009 Jun; 6(2):107-12. PubMed ID: 22477899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' awareness of recovery mediates the link between clinical and level of functional remission in schizophrenia to a larger extent in those treated with long-acting antipsychotics.
    Mallet J; Dondé C; Dubertret C; Gorwood P
    Ther Adv Psychopharmacol; 2024; 14():20451253241231269. PubMed ID: 38370363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of functional remission in schizophrenic disorder. The FROGS Scale].
    Rouillon F; Baylé FJ; Gorwood P; Lancrenon S; Lançon C; Llorca PM;
    Encephale; 2013 May; 39 Suppl 1():S15-21. PubMed ID: 23541143
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.